IC
ZYME icon

Ikarian Capital’s Zymeworks ZYME Stock Holding History

Ikarian Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-375,200
Closed -$17.7M – 332
2020
Q4 		$17.7M Sell
375,200
-124,800
-25% -$5.8M 0.78% 26
2020
Q3 		$23.3M Sell
500,000
-200,000
-29% -$6.87M 1.69% 11
2020
Q2 		$25.2M Buy
+700,000
New +$25.8M 2.01% 8

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ikarian Capital's ZYME Position: Q4 2025 in Review

Ikarian Capital sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 72,787 shares — an estimated $1.24M sold.

Ikarian Capital first reported a position in ZYME in Q4 2020 and held it in 3 quarters. The position peaked at $1.24M in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

  • Ikarian Capital reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
  • Ikarian Capital sold 72,787 Zymeworks shares in Q4 2025, an estimated $1.24M.
  • Ikarian Capital first reported a position in Zymeworks in Q4 2020 and held it in 3 quarters.
  • Ikarian Capital's Zymeworks position peaked at $1.24M in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on Ikarian Capital's 13F filing for Q4 2025, filed 18 Feb 2026.